Great news31 Jan 2025 09:23
Great news today. This is what we have been waiting for. Front line patients being treated as opposed to only end of life.
Remember that around June 2023 RNS spoke of the biomarker data which selects the patients bex works best on.
Expect the results to be excellent.
Formost, congratulations to the patients on the trial!
Question is, when will a partner deal get signed? I suspect they want finalised phase 2 data first.
So in the meantime.. do we have enough funds? I suppose that's the reason for the stagnant share price despite today's update.
Whats our options? The last placing was.said.to.be the last one erver.. bold statement.. and risky statement.
However after the placing the FDA changed the finish line by telling them they would approve phase 3 with a smaller amount of patients.. Great news again.. but money would be needed.
Again, this would be funded by a partner...
They do have options of borrowing money to buy them time.. I think I would prefer a partner on board..
I hope Juhu knows what's he's doing..